Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

Nature Neuroscience

Volumn 17, Issue 2, 2014, Pages 304-311

  Khan, Usman A ^a,b   Liu, Li ^a   Provenzano, Frank A ^a   Berman, Diego E ^a   Profaci, Caterina P ^a   Sloan, Richard ^a   Mayeux, Richard ^a   Duff, Karen E ^a   Small, Scott A ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN DISEASE; BRAIN MAPPING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENTORHINAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; LATERAL ENTORHINAL CORTEX; LATERAL ENTORHINAL CORTEX DYSFUNCTION; MEDICAL ENTORHINAL CORTEX; METABOLIC DISORDER; MILD COGNITIVE IMPAIRMENT; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PARIETAL CORTEX; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; BRAIN MAPPING; COGNITION DISORDERS; CORTICAL SPREADING DEPRESSION; DISEASE PROGRESSION; ENTORHINAL CORTEX; FEMALE; FUNCTIONAL LATERALITY; GENE EXPRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; OXYGEN; TAU PROTEINS;

EID: 84893763207     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3606     Document Type: Article

References (60)

1. Braak, H. & Del Tredici, K. Alzheimer's disease: pathogenesis and prevention. Alzheimers Dement. 8, 227-233 (2012).
2. Gómez-Isla, T. et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500 (1996).
3. Whitwell, J.L. et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130, 1777-1786 (2007).
4. Moreno, H. et al. Imaging the abeta-related neurotoxicity of Alzheimer disease. Arch. Neurol. 64, 1467-1477 (2007).
5. Näslund, J. et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283, 1571-1577 (2000).
6. Lue, L.F. et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol. 155, 853-862 (1999).
7. Desikan, R.S. et al. Amyloid-beta-associated clinical decline occurs only in the presence of elevated P-tau. Arch. Neurol. 69, 709-713 (2012).
8. Canto, C.B. & Witter, M.P. Cellular properties of principal neurons in the rat entorhinal cortex. I. The lateral entorhinal cortex. Hippocampus 22, 1256-1276 (2012).
9. Canto, C.B. & Witter, M.P. Cellular properties of principal neurons in the rat entorhinal cortex. II. The medial entorhinal cortex. Hippocampus 22, 1277-1299 (2012).
10. Tsao, A., Moser, M.B. & Moser, E.I. Traces of experience in the lateral entorhinal cortex. Curr. Biol. 23, 399-405 (2013).
11. Canto, C.B., Wouterlood, F.G. & Witter, M.P. What does the anatomical organization of the entorhinal cortex tell us? Neural Plast. 2008, 381243 (2008).
12. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789-791 (2002).
13. Sperling, R.A. et al. Toward defning the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280-292 (2011).
14. Lin, W., Celik, A. & Paczynski, R.P. Regional cerebral blood volume: a comparison of the dynamic imaging and the steady state methods. J. Magn. Reson. Imaging 9, 44-52 (1999).
15. Raichle, M.E. Positron emission tomography. Annu. Rev. Neurosci. 6, 249-267 (1983).
16. Belliveau, J.W. et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 254, 716-719 (1991).
17. González, R.G. et al. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fudeoxyglucose F 18. AJNR Am. J. Neuroradiol. 16, 1763-1770 (1995).
18. Small, S.A., Chawla, M.K., Buonocore, M., Rapp, P.R. & Barnes, C.A. From the cover: imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc. Natl. Acad. Sci. USA 101, 7181-7186 (2004).
19. Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE 7, e31302 (2012).
20. de Calignon, A. et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697 (2012).
21. Harris, J.A. et al. Transsynaptic progression of amyloid-beta-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 68, 428-441 (2010).
22. Sabuncu, M.R., Yeo, B.T., Van Leemput, K., Vercauteren, T. & Golland, P. Asymmetric image-template registration. Med. Image Comput. Comput. Assist. Interv. 12, 565-573 (2009).
23. Brickman, A.M., Stern, Y. & Small, S.A. Hippocampal subregions differentially associate with standardized memory tests. Hippocampus 21, 923-928 (2011).
24. Elias, M.F. et al. The preclinical phase of alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch. Neurol. 57, 808-813 (2000).
25. Yasuda, M. & Mayford, M.R. CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory. Neuron 50, 309-318 (2006).
26. Moreno, H., Hua, F., Brown, T. & Small, S. Longitudinal mapping of mouse cerebral blood volume with MRI. NMR Biomed. 19, 535-543 (2006).
27. Lewis, J. et al. Enhanced neurofbrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491 (2001).
28. Jicha, G.A., Berenfeld, B. & Davies, P. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J. Neurosci. Res. 55, 713-723 (1999).
29. Hevner, R.F. & Wong-Riley, M.T. Entorhinal cortex of the human, monkey, and rat: metabolic map as revealed by cytochrome oxidase. J. Comp. Neurol. 326, 451-469 (1992).
30. Solodkin, A. & Van Hoesen, G.W. Entorhinal cortex modules of the human brain. J. Comp. Neurol. 365, 610-617 (1996).
31. Kageyama, G.H. & Wong-Riley, M.T. Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specifc neuronal types and afferent pathways. Neuroscience 7, 2337-2361 (1982).
32. Schon, K., Hasselmo, M.E., Lopresti, M.L., Tricarico, M.D. & Stern, C.E. Persistence of parahippocampal representation in the absence of stimulus input enhances longterm encoding: a functional magnetic resonance imaging study of subsequent memory after a delayed match-to-sample task. J. Neurosci. 24, 11088-11097 (2004).
33. Olsen, R.K. et al. Performance-related sustained and anticipatory activity in human medial temporal lobe during delayed match-to-sample. J. Neurosci. 29, 11880-11890 (2009).
34. Suzuki, W.A. & Amaral, D.G. Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents. J. Comp. Neurol. 350, 497-533 (1994).
35. Young, B.J., Otto, T., Fox, G.D. & Eichenbaum, H. Memory representation within the parahippocampal region. J. Neurosci. 17, 5183-5195 (1997).
36. Albert, M.S. The ageing brain: normal and abnormal memory. Phil. Trans. R. Soc. Lond. B 352, 1703-1709 (1997).
37. Petersen, R.C., Smith, G., Kokmen, E., Ivnik, R.J. & Tangalos, E.G. Memory function in normal aging. Neurology 42, 396-401 (1992).
38. Stranahan, A.M., Haberman, R.P. & Gallagher, M. Cognitive decline is associated with reduced reelin expression in the entorhinal cortex of aged rats. Cereb. Cortex 21, 392-400 (2011).
39. Meguro, K. et al. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain 122, 1519-1531 (1999).
40. Klunk, W.E. et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol. 55, 306-319 (2004).
41. Kageyama, G.H. & Wong-Riley, M.T. Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specifc neuronal types and afferent pathways. Neuroscience 7, 2337-2361 (1982).
42. Das, U. et al. Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79, 447-460 (2013).
43. Ittner, L.M. et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397 (2010).
44. Sapir, T., Frotscher, M., Levy, T., Mandelkow, E.M. & Reiner, O. Tau's role in the developing brain: implications for intellectual disability. Hum. Mol. Genet. 21, 1681-1692 (2012).
45. Brickman, A.M. et al. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch. Neurol. 65, 1053-1061 (2008).
46. Stern, Y. et al. Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantifed correction for the effects of education. Arch. Neurol. 49, 453-460 (1992).
47. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944 (1984).
48. Hughes, C.P., Berg, L., Danziger, W.L., Coben, L.A. & Martin, R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry 140, 566-572 (1982).
49. Manly, J.J. et al. Frequency and course of mild cognitive impairment in a multiethnic community. Ann. Neurol. 63, 494-506 (2008).
50. Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-481 (2005).
51. Jankowsky, J.L. et al. Environmental enrichment mitigates cognitive defcits in a mouse model of Alzheimer's disease. J. Neurosci. 25, 5217-5224 (2005).
52. Moreno, H., Hua, F., Brown, T. & Small, S. Longitudinal mapping of mouse cerebral blood volume with MRI. NMR Biomed. 19, 535-543 (2006).
53. Reuter, M., Rosas, H.D. & Fischl, B. Highly accurate inverse consistent registration: a robust approach. Neuroimage 53, 1181-1196 (2010).
54. Frangi, A., Niessen, W., Vincken, K. & Viergever, M. Multiscale vessel enhancement fltering. Med. Image Comput. Comput, Assist. Interv. 1496, 130-137 (1998).
55. Desikan, R.S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968-980 (2006).
56. Tustison, N.J. et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 29, 1310-1320 (2010).
57. Richards, K. et al. Segmentation of the mouse hippocampal formation in magnetic resonance images. Neuroimage 58, 732-740 (2011).
58. Zeineh, M.M., Engel, S.A. & Bookheimer, S.Y. Application of cortical unfolding techniques to functional MRI of the human hippocampal region. Neuroimage 11, 668-683 (2000).
59. Mueller, S.G. et al. Measurement of hippocampal subfelds and age-related changes with high resolution MRI at 4T. Neurobiol. Aging 28, 719-726 (2007).
60. Paxinos, G. & Franklin, K. The Mouse Brain in Stereotaxic Coordinates (Academic Press, 2001).